Overview

Phase II Study of Oxaliplatin in Combination With 5-Fu in 1st Line Treatment of Locally Advanced or Metastatic Squamous Cell Carcinoma of the Head and Neck

Status:
Completed

Trial end date:
2003-02-01

Target enrollment:

Participant gender:

Summary

To evaluate the efficacy of first line oxaliplatin in combination with 5-fluorouracil (5-FU) in patients with advanced inoperable or metastatic head and neck cancer and to investigate the safety profile of this regimen in the above indication and consider other criteria of efficacy (clinical benefit, survival)

Phase:

Phase 2

Details

Lead Sponsor:

Sanofi

Treatments:

Fluorouracil
Oxaliplatin